Zhang, X., Goel, V., & Robbie, G. J. (2019). Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin‐Mediated Amyloidosis. J Clin Pharmacol.
Citação norma ChicagoZhang, Xiaoping, Varun Goel, and Gabriel J. Robbie. "Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin‐Mediated Amyloidosis." J Clin Pharmacol 2019.
Citação norma MLAZhang, Xiaoping, Varun Goel, and Gabriel J. Robbie. "Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin‐Mediated Amyloidosis." J Clin Pharmacol 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.